SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is experiencing significant upward momentum and record volume as the community anticipates major catalysts, including the 80th trial event and potential buyout interest. The stock's rapid appreciation has sparked intense debate over a potential short squeeze, with investors closely watching borrowing fees and institutional activity while debating the long-term potential of the company's oncology pipeline.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is trending as investors monitor its recent inclusion in the Russell 2000 and 3000 indexes, which has sparked significant debate regarding potential liquidity inflows versus ongoing volatility and dilution concerns. The community is deeply divided, with bulls highlighting the company's expanding defense contracts and drone sector tailwinds, while bears remain focused on persistent downward price trends and recent resale registration filings.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is gaining investor attention as it prepares to initiate a pivotal Phase 3 clinical trial for its lead candidate in non-small cell lung cancer, a major catalyst that follows its established Phase 3 success in prostate cancer. The community is actively discussing the stock's significant long-term upside potential, citing the recent hiring of a new Chief Commercial Officer and expectations that the company is a prime candidate for a multi-billion dollar acquisition by major pharmaceutical players.

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment is trending as investors react to a significant earnings beat and a massive $1.2 billion backlog, signaling strong demand despite some investor caution regarding forward guidance and margin pressure. The community is actively debating the stock's potential for a short squeeze against concerns over internal accounting risks and class-action legal headwinds.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is facing extreme downward pressure amid a barrage of analyst downgrades, analyst price target cuts, and mounting concerns over competition from walled gardens and other ad-tech firms. While some investors argue the company is fundamentally undervalued and a prime turnaround candidate, the community is deeply divided, with many traders expressing frustration over the lack of positive corporate catalysts and aggressive short selling.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is rallying as traders capitalize on the company's emerging solid-state transformer technology, which is being positioned as a key infrastructure play for the booming AI data center market. Community sentiment is currently driven by a mix of heavy short-covering, bullish insider buying, and high expectations for the company to secure major partnerships in the power hardware sector.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending as investors react to a new manufacturing alliance with Toyota and ongoing progress in FAA certification milestones. The community is sharply divided, with bulls pointing to the company's strong cash position and strategic partnerships, while bears continue to highlight concerns over cash burn and potential share dilution.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is trending as investors monitor the upcoming closing of its acquisition of TopBuild, with the community actively debating the impact of short interest, recent debt financing success, and the potential for a long-term valuation turnaround. Discussion remains heavily focused on the stock's volatility, dilution concerns, and the conviction among long-term holders that the company's ambitious M&A strategy will unlock significant value as the deal finalizes.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore is trending as the community closely monitors operational ramp-up progress and potential federal support via the Defense Production Act, while debating the impact of legal disputes with California regulators on the stock's valuation. Investors are actively discussing the company's ability to successfully refinance its debt and achieve targeted production milestones following the start of crude oil sales to Chevron.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors speculate on near-term catalysts, including potential international expansion for its Anktiva therapy and upcoming Q2 sales reporting. The community is actively debating the impact of the stock's recent performance on institutional holdings and short interest, while dismissing noise surrounding index rebalancing in favor of long-term growth driven by global manufacturing and clinical progress.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Concorde International (CIGL) Investors of Securities Class Action Deadline on May 20, 2026

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Concorde International Group, Ltd. (Concorde or the Company) (NASDAQ: CIGL) and reminds investors of the May 20, 2026 deadline to seek the role of lead plaintiff in a federal securities class...

CIGL Shareholder Alert: Concorde International Group, Ltd. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm

CIGL Shareholder Alert: Concorde International Group, Ltd. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm CIGL Shareholder Alert: Concorde International Group...

What's Going On With Concorde Stock Friday?

Concorde (NASDAQ: YOOV) shares drop 14% on Friday as retail traders take profits following a massive 114% Thursday rally.read more...

CIGL UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Concorde International (CIGL) Investors of Securities Class Action Deadline on May 20, 2026

CIGL UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Concorde International (CIGL) Investors of Securities Class Action Deadline on May 20, 2026 CIGL UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds...

CIGL, YOOV Deadline: CIGL, YOOV Investors Have Opportunity to Lead Concorde International Group Ltd. Securities Fraud Lawsuit

CIGL, YOOV Deadline: CIGL, YOOV Investors Have Opportunity to Lead Concorde International Group Ltd. Securities Fraud Lawsuit CIGL, YOOV Deadline: CIGL, YOOV Investors Have Opportunity to Lead...

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Concorde International Group, Ltd. of Class Action Lawsuit and Upcoming Deadlines - CIGL

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Concorde International Group, Ltd. of Class Action Lawsuit and Upcoming Deadlines - CIGL INVESTOR ALERT...

Wall Street’s Next Mania

A powerful speculative narrative is taking shape, as Wall Street is searching for leverage to the next wave of AI infrastructure demand and geopolitical reshoring trends. From sovereign GPU deployments and rare earth mineral supply chains to photonic networking and edge-compression technology, investors are increasingly rewarding companies positioned around next-generation compute, defense readiness, and data-intensive applications. $YOOV, $SNAL, $XERI, $MOBX, $AIIO, $AEHL, $POET, $PCT, $ALP

CIGL UPCOMING DEADLINE : The Gross Law Firm Alerts Concorde International Group, Ltd. Stockholders of Securities Class Action - Contact the Firm

CIGL UPCOMING DEADLINE : The Gross Law Firm Alerts Concorde International Group, Ltd. Stockholders of Securities Class Action - Contact the Firm CIGL UPCOMING DEADLINE : The Gross Law Firm Alerts...

DEADLINE APPROACHING: Berger Montague Advises Concorde International Group, LTD. (NASDAQ: CIGL) Investors to Inquire About a Securities Fraud Class Action by May 18, 2026

DEADLINE APPROACHING: Berger Montague Advises Concorde International Group, LTD. (NASDAQ: CIGL) Investors to Inquire About a Securities Fraud Class Action by May 18, 2026 DEADLINE APPROACHING: Berger...

CIGL, YOOV Investors Have Opportunity to Lead Concorde International Group Ltd. Securities Fraud Lawsuit

CIGL, YOOV Investors Have Opportunity to Lead Concorde International Group Ltd. Securities Fraud Lawsuit CIGL, YOOV Investors Have Opportunity to Lead Concorde International Group Ltd. Securities...

Concorde International Group Ltd. is a holding company, which engages in the provision of manpower with innovative technology to enhance security solutions efficiently. Its services include i-Guarding, man-guarding, and consultancy and training. The company was founded by Swee Kheng Chua in 1997 and is headquartered in Singapore.

Concorde International Group Ltd. - Ordinary Shares - Class A

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.386
Prev Close	$0.4104
Open	$0.41
Dividend Yield	0.00%
50-Day Moving Average	$0.9327
Beta	3.55
Avg. Volume	3.51M
PE Ratio	-0.66

52-Week High	$31.06
52-Week Low	$0.3847
Market Capitalization	$87.62M
EPS (Annual)	-$0.5648
Price to Book	2.90
Revenue Per Employee	$114,453.61

Feed

News

Sentiment

Fundamentals

Info

YOOVConcorde International Group Ltd. - Ordinary Shares - Class A

Latest YOOV News